Literature DB >> 12578852

Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation.

Yiqiang Wang1, Arthur M Krieg.   

Abstract

DNA or oligodeoxynucleotides (ODN) containing unmethylated CpG motifs (CpG DNA) activate antigen-presenting cells and switch on T(h)1 immunity to antigen. B cells are synergistically activated by CpG DNA in combination with non-physiologic B cell stimulators such as polyclonal mitogen and surface Ig cross-linkers. This study shows the unexpected finding that not only CpG ODN, but also non-CpG and methylated ODN synergize with specific antigen, hen egg lysozyme (HEL), in stimulating HEL-specific B cells to proliferate, to express the early activation marker CD69 and to activate the NF-kappaB pathway. In vivo, non-CpG and methylated CpG ODN also enhanced anti-HEL antibody production in HEL-immunized mice, with a bias towards the production of T(h)1-associated isotypes. The synergy with all ODN to enhance B cell immune function was epitope-specific since neither denatured HEL nor other antigens enhanced the ODN effect on HEL-specific B cells. Furthermore, the synergy was independent of whether the ODN backbone was phosphorothioate or phosphodiester, or whether natural vertebrate genomic DNA was used. In all functional analyses, non-CpG and methylated CpG ODN showed lower activity than CpG ODN. These studies demonstrate that the presence of specific physiologic antigen might broaden the spectrum of DNA/ODN that stimulate B cells, with potential implications for the initiation and regulation of normal and pathologic immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578852     DOI: 10.1093/intimm/dxg020

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Different sources of "help" facilitate the antibody response to hepatitis D virus delta antigen.

Authors:  Peter Seizer; Petra Riedl; Jörg Reimann; Reinhold Schirmbeck
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

2.  Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6.

Authors:  Michelle A Kilmon; Nikki J Wagner; Alaina L Garland; Li Lin; Katja Aviszus; Lawrence J Wysocki; Barbara J Vilen
Journal:  Blood       Date:  2007-09-01       Impact factor: 22.113

3.  Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes.

Authors:  Shulamit Naor; Zohar Keren; Tomer Bronshtein; Efrat Goren; Marcelle Machluf; Doron Melamed
Journal:  J Neurol       Date:  2009-03-12       Impact factor: 4.849

4.  Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.

Authors:  Melissa B Uccellini; Liliana Busconi; Nathaniel M Green; Patricia Busto; Sean R Christensen; Mark J Shlomchik; Ann Marshak-Rothstein; Gregory A Viglianti
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

5.  Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells.

Authors:  Peimin Zhu; Xiaohong Liu; Laura S Treml; Michael P Cancro; Bruce D Freedman
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

6.  Poke weed mitogen requires Toll-like receptor ligands for proliferative activity in human and murine B lymphocytes.

Authors:  Isabelle Bekeredjian-Ding; Sandra Foermer; Carsten J Kirschning; Marijo Parcina; Klaus Heeg
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

7.  Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.

Authors:  Sean R Christensen; Michael Kashgarian; Lena Alexopoulou; Richard A Flavell; Shizuo Akira; Mark J Shlomchik
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

8.  CpG Oligodeoxynucleotides Modulate Innate and Adaptive Functions of IgM+ B Cells in Rainbow Trout.

Authors:  Rocío Simón; Patricia Díaz-Rosales; Esther Morel; Diana Martín; Aitor G Granja; Carolina Tafalla
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

Review 9.  Toll-like receptors in systemic autoimmune disease.

Authors:  Ann Marshak-Rothstein
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

10.  Non-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching.

Authors:  Melinda Herbáth; Krisztián Papp; Anna Erdei; József Prechl
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.